semaglutide weight loss calculator free BMI Online for Home Use | Check Body Mass Index & Obesity Risk Semaglutide (Ozempic® & Wegovy®) Before

Research indicates that Semaglutide may offer cardiovascular benefits, including a reduced risk of heart attack and stroke

Prime Therapeutics leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years 3 Article Only 8% of individuals (or 1 in 12) initiating a glucagon-like peptide-1 (GLP-1) agonist drug for obesity without diabetes continued to do so at three years, according to the latest real-world research from pharmacy solutions partner Prime Therapeutics LLC (Prime)

If making a difference matters to you, then you matter to us

During this visit, you'll meet with a weight loss counselor, discuss your health history and goals, learn about program options, and get a clear picture of what success can look like for you